Notably, the antibodies effectively targeted leukemic stem cells in bone marrow samples and mouse models, which Flynn noted as “critical” because a handful of leukemia stem cells can ...

Acute myelogenous leukemia, or AML, remains one of the most aggressive blood cancers. Each year, around 44,000 people in the U.

All the patients in the phase 2 study received cyclophosphamide, tacrolimus and mycophenolate mofetil for graft-vs-host ...

A new cancer treatment discovered by the University of California, San Diego Sanford Stem Cell Institute (SSCI) and developed ...

Congratulations to Emeline Boet (PhD Tamburini's group), winner of the poster session held at the CRTOH retreat on May 26-27, 2025 in the Post Doc Category.

First patient dosed with Debiopharm's first-in-class CD37 targeted antibody drug conjugate (ADC) in a Phase 1/2, multicenter, open-label trial, for patients with acute myeloid leukemia (AML) Debiophar ...

Two allogeneic stem cell transplants, including a complex and highly challenging haploidentical (half-match) transplant were performed successfully at KIMS-Health Cancer Centre, marking a significant ...